Catalyst Pharmaceuticals, Inc.
CPRX
$31.16
$0.020.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 755.86M | 709.17M | 689.89M | 652.80M | 580.66M |
| Total Receivables | 131.31M | 128.27M | 106.80M | 66.31M | 72.26M |
| Inventory | 34.93M | 37.17M | 28.03M | 18.65M | 19.78M |
| Prepaid Expenses | 15.58M | 17.39M | 24.23M | 19.73M | 12.57M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.72M | 2.04M | 3.50M | 1.24M | 452.00K |
| Total Current Assets | 940.39M | 894.03M | 852.45M | 758.74M | 685.72M |
|
|
|||||
| Total Current Assets | 940.39M | 894.03M | 852.45M | 758.74M | 685.72M |
| Net Property, Plant & Equipment | 2.85M | 2.97M | 3.09M | 3.23M | 3.40M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 121.97M | 131.67M | 128.64M | 137.98M | 147.33M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 55.11M | 52.77M | 48.26M | 50.70M | 48.22M |
| Total Assets | 1.15B | 1.10B | 1.05B | 971.92M | 908.87M |
|
|
|||||
| Total Accounts Payable | 7.15M | 11.20M | 9.10M | 5.53M | 11.20M |
| Total Accrued Expenses | 26.54M | 61.66M | 53.52M | 41.76M | 30.95M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 446.00K | 437.00K | 428.00K | 419.00K | 410.00K |
| Total Finance Division Other Current Liabilities | 98.26M | 73.86M | 65.69M | 65.30M | 69.10M |
| Total Other Current Liabilities | 98.26M | 73.86M | 65.69M | 65.30M | 69.10M |
| Total Current Liabilities | 132.40M | 147.15M | 128.74M | 113.01M | 111.65M |
|
|
|||||
| Total Current Liabilities | 132.40M | 147.15M | 128.74M | 113.01M | 111.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.24M | 2.35M | 2.46M | 2.57M | 2.68M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 280.00K | 209.00K | 161.00K | 309.00K | 259.00K |
| Total Liabilities | 134.91M | 149.71M | 131.36M | 115.89M | 114.59M |
|
|
|||||
| Common Stock & APIC | 489.34M | 480.08M | 473.46M | 461.99M | 452.40M |
| Retained Earnings | 523.35M | 474.19M | 446.79M | 394.01M | 341.90M |
| Treasury Stock & Other | 8.00K | -- | -- | 31.00K | -17.00K |
| Total Common Equity | 1.01B | 954.27M | 920.25M | 856.03M | 794.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.01B | 954.27M | 920.25M | 856.03M | 794.28M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.01B | 954.27M | 920.25M | 856.03M | 794.28M |
|
|
|||||